Published in State and Local Health Law Weekly, February 17th, 2005
"It's just plain ethically wrong and it's designed to color our judgment," Dean Abramson, MD, of Gastroenterologists P.C. said of the practice. "I don't think patients realize how much drug companies spend on this."
According to a report by the California Public Interest Research Group, U.S. spending on "detailing" efforts by drug representatives to reach doctors directly totals nearly $5 billion annually, costs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of State and Local Health Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.